Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world experience of axicabtagene ciloleucel, a CD19-directed CAR T-cell therapy, in the second-line treatment of early relapsed or primary refractory large B-cell lymphoma.
Othman T, Baird JH, Pak S, Mei M, Herrera AF, Mansour J, Shouse G, Sahebi F, Spielberger R, Cai JL, Farol L, Godfrey J, Kallam A, Phillips T, Popplewell L, Siddiqi T, Forman S, Budde LE. Othman T, et al. Among authors: herrera af. Br J Haematol. 2024 May 26. doi: 10.1111/bjh.19521. Online ahead of print. Br J Haematol. 2024. PMID: 38797530 No abstract available.
Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis.
Epperla N, Hashmi H, Ahn KW, Allbee-Johnson M, Chen AI, Wirk B, Kanakry JA, Lekakis L, Kharfan-Dabaja MA, Scordo M, Riedell PA, Jain T, Shadman M, Sauter C, Hamadani M, Herrera AF, Ahmed S. Epperla N, et al. Among authors: herrera af. Br J Haematol. 2024 May 26. doi: 10.1111/bjh.19569. Online ahead of print. Br J Haematol. 2024. PMID: 38797526 No abstract available.
Assessment of pain relief after four botulinum toxin A injection cycles in patients with post-stroke lower limb spasticity: A prospective, observational study.
Vázquez Doce A, De León García FJ, Mena A, Ortiz-Fernández L, Spottorno MP, Medina F, Maisonobe P, Herrera A, García I, Juan-García FJ; RELIEF investigators group. Vázquez Doce A, et al. Among authors: herrera a. Rehabilitacion (Madr). 2024 May 24;58(3):100856. doi: 10.1016/j.rh.2024.100856. Online ahead of print. Rehabilitacion (Madr). 2024. PMID: 38795502
Mechanical heterogeneity in a soft biomaterial niche controls BMP2 signaling.
Brauer E, Herrera A, Fritsche-Guenther R, Görlitz S, Leemhuis H, Knaus P, Kirwan JA, Duda GN, Petersen A. Brauer E, et al. Among authors: herrera a. Biomaterials. 2024 May 16;309:122614. doi: 10.1016/j.biomaterials.2024.122614. Online ahead of print. Biomaterials. 2024. PMID: 38788455 Free article.
Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis.
Wang TP, Ahn KW, Shadman M, Kaur M, Ahmed N, Bacher U, Cerny J, Chen A, Epperla N, Frigault M, Grover N, Haverkos B, Hill B, Hossain N, Iqbal M, Jain T, Krem MM, Maakaron J, Modi D, Alhaj Moustafa M, Riedell P, Savani B, Sica RA, Sureda A, Wudhikarn K, Herrera AF, Sauter C, Hamadani M, Jimenez Jimenez A. Wang TP, et al. Among authors: herrera af. Leukemia. 2024 May 15. doi: 10.1038/s41375-024-02242-6. Online ahead of print. Leukemia. 2024. PMID: 38750138
Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.
Yi S, Yan Y, Jin M, Bhattacharya S, Wang Y, Wu Y, Yang L, Gine E, Clot G, Chen L, Yu Y, Zou D, Wang J, Phan AT, Cui R, Li F, Sun Q, Zhai Q, Wang T, Yu Z, Liu L, Liu W, Lyv R, Sui W, Huang W, Xiong W, Wang H, Li C, Xiao Z, Hao M, Wang J, Cheng T, Bea S, Herrera AF, Danilov A, Campo E, Ngo VN, Qiu L, Wang L. Yi S, et al. Among authors: herrera af. J Clin Invest. 2024 May 15;134(10):e182153. doi: 10.1172/JCI182153. J Clin Invest. 2024. PMID: 38747295 Free PMC article. No abstract available.
Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States.
Lurain K, Zarif TE, Ramaswami R, Nassar AH, Adib E, Abdel-Wahab N, Chintapally N, Drolen CE, Feldman T, Haykal T, Nebhan CA, Kambhampati S, Li M, Mittra A, Lorentsen M, Kim C, Drakaki A, Morse M, Johnson DB, Mangla A, Dittus C, Ravi P, Baiocchi RA, Chiao EY, Rubinstein PG, Yellapragada SV, LaCasce AS, Sonpavde GP, Naqash AR, Herrera AF. Lurain K, et al. Among authors: herrera af. Clin Lymphoma Myeloma Leuk. 2024 Apr 5:S2152-2650(24)00134-4. doi: 10.1016/j.clml.2024.03.011. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38714474
1,196 results